|
?:authorAffiliation
|
-
[\'Pituitary Center, Oregon Health & Science University, Mail Code CH8N, 3303 South Bond Ave, Portland, OR, 97239, USA. fleseriu@ohsu.edu.\', \'Department of Neurosurgery, University Hospital Erlangen, Erlangen, Germany.\', \'Pituitary Center, Oregon Health & Science University, Mail Code CH8N, 3303 South Bond Ave, Portland, OR, 97239, USA.\', \'Veterans Affairs Medical Center, Portland, OR, USA.\', \'Neuroendocrinology Unit, Division of Endocrinology and Metabolism, University of Pittsburgh, Pittsburgh, PA, USA.\', \'Division de Endocrinología, Hospital Militar Central, Buenos Aires, Argentina.\', \'Addenbrooke\'s Hospital, University of Cambridge and NIHR Cambridge Biomedical Research Centre, Wellcome Trust-MRC Institute of Metabolic Science, Cambridge, UK. mg299@medschl.cam.ac.uk.\', \'Department of Endocrinology, St Vincent\'s Hospital, Sydney, Australia.\', \'Garvan Institute of Medical Research, Sydney, NSW, Australia.\', \'Facultad de Medicina, Hospital de Clínicas, Clínica de Endocrinología Y Metabolismo, Universidad de La República, Montevideo, Uruguay.\', \'Department of Neurosurgery, Hospital Pablo Tobon Uribe and Clinica Medellin - Grupo Quirónsalud, Medellin, Colombia.\', \'Neuroendocrine Unit and Neuroendocrine and Pituitary Tumor Clinical Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.\', \'National Hospital for Neurology and Neurosurgery, London, UK.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}